Differential effects of estrogen and micronized progesterone or medroxyprogesterone acetate on cognition in postmenopausal women.

Trial Profile

Differential effects of estrogen and micronized progesterone or medroxyprogesterone acetate on cognition in postmenopausal women.

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Aug 2011

At a glance

  • Drugs Conjugated estrogens (Primary) ; Medroxyprogesterone (Primary) ; Progesterone (Primary)
  • Indications Menopausal syndrome
  • Focus Pharmacodynamics
  • Most Recent Events

    • 10 Aug 2011 New trial record
    • 22 Jun 2011 Results published in Fertility and Sterility.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top